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Background: Diabetic patients with chronic kidney disease (CKD), as defined by a reduced glomerular filtration rate
(GFR), are at greater risk for cardiovascular and renal events and mortality. The aim of this study was to determine
the prevalence of CKD among diabetic patients attending a hospital in southern Ethiopia, and to assess
underdiagnosis of renal insufficiency among those with normal serum creatinine.
Methods: A total of 214 randomly selected diabetics attending the follow-up clinic at Butajira hospital of southern
Ethiopia participated in this study during the period from September 1 to October 31, 2013. All patients completed
an interviewer-administered questionnaire and underwent clinical assessment. The simplified Modification of Diet in
Renal Disease (MDRD) and Cockroft-Gault (C-G) equations were used to estimate GFR (eGFR) from serum creatinine.
Results: CKD, defined as eGFR < 60 ml/min/1.73 m2, was present in 18.2% and 23.8% of the study participants
according to the MDRD and Cockcroft-Gault (C-G) equations, respectively. Only 9.8% of the total participants, and
48.7% (for the MDRD) and 37.3% (for C-G) of those with eGFR <60 ml/min/1.73 m2 had abnormal serum creatinine
values, i.e. > 1.5 mg/dl. Normal serum creatinine was observed in 90.2% of participants attending the hospital. A
large proportion of participants ranging from 38.9-56.5% have shown to have mild to moderate renal insufficiency
(stage 2–3 CKD) despite normal creatinine levels. CKD, eGFR < 60 ml/min/1.73 m2, was found in 10.4 and 16.9% of
participants with normal serum creatinine using the MDRD and C-G equations, respectively.
Conclusion: CKD is present in no less than 18% of diabetics attending the hospital, but it is usually undiagnosed. A
significant number of diabetics have renal insufficiency corresponding to stages 2–3 CKD despite normal creatinine
levels. Therefore, GFR should be considered as an estimate of renal insufficiency, regardless of serum creatinine
levels being in normal range.
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Chronic kidney disease (CKD), characterized by a glomeru-
lar filtration rate (GFR) of less than 60 ml/min/1.73 m2, is a
common and serious complication of diabetes [1]. Health
consequences are substantial, with sufferers at increased
risk of all-cause and cardiovascular mortality, progression
to kidney failure, cardiovascular disease (CVD) and hospi-
talizations [2,3]. For patients with diabetes and CKD, the* Correspondence: temafiseha@gmail.com
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unless otherwise stated.risk of hypertension, anemia, malnutrition, bone and
mineral disorders, and retinopathy is higher as com-
pared to patients with normal renal function [4,5]. There
is an even higher prevalence of hypoglycemia due to
decreased clearance of hypoglycemic agents or impaired
renal gluconeogenesis [6].
Assessment of renal function is therefore important, as
detecting CKD during its initial stages provides the op-
portunity for early therapeutic interventions to prevent
or delay the onset of disease or complications and to im-
prove outcomes. The GFR, an important component in
the diagnosis of CKD, is accepted as the best index ofThis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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exogenous filtration markers such as inulin or iothala-
mate are the definitive measures, but none of these are
practical or economical for routine use [8].
Serum creatinine (SCr) has been proposed as an en-
dogenous marker of GFR and used most frequently to
assess renal function in clinical practices. However, SCr
level, which is affected by factors other than the GFR, is
insufficiently sensitive to detect CKD on its own, and
might remain in the normal range despite the renal
function is significantly impaired [9,10].
Currently, an estimated GFR (eGFR) derived from pre-
diction equations has been suggested as a simple, rapid
and reliable means of assessing renal function, and have
been shown to be more accurate in estimating GFR at
levels below 60 ml/min/1.73 m2 [8,11,12]. Consequently,
available guidelines recommend the annual measure-
ment of SCr for eGFR in all adults with diabetes and the
use of prediction equations that incorporate patient’s
age, sex, race and body size for CKD diagnosis and sta-
ging renal insufficiency [1,13-15].
Despite the fact that diabetic patients are more likely
to have CKD, and thus suffer extra morbidity and mor-
tality than those without the disease [16,17]; there are
virtually no published studies on the prevalence of CKD
among diabetic patients in Ethiopia. More than this,
many physicians relay on SCr as a measure of renal
function rather than using for eGFR and interpret nor-
mal SCr levels as evidence of normal renal function.
Therefore, the aim of this study was to estimate the
prevalence of CKD among diabetic patients attending
Butajira Hospital of southern Ethiopia, and to assess un-
derdiagnosis of renal insufficiency among those with
normal SCr.
Methods
From 568 registered diabetic patients, 229 random samples
of people aged 18 years and above were drawn out using a
table of random numbers constructed from the register. A
total of 214 diabetics attending the follow-up clinic of
Butajira Hospital, southern Ethiopia from September 1 to
October 31 2013 were included in this cross sectional
study. Butajira Hospital is located in Butajira town, 130 km
mid-south of the capital city of Ethiopia, Addis Ababa. The
hospital registers and treats all diagnosed diabetic patients
and provides primary diabetes patient care.
The study was approved by the Research Ethics Com-
mittee of Jimma University. An informed verbal consent
was taken from all the patients enrolled. Participants,
who were recruited after being screened and counseled
by their clinicians, were adults (≥18 years) attending the
diabetic clinic for follow-up. Patients were excluded if
they were pregnant, hospitalized, have acute illnesses
(fever), treated with dialysis and if they were not fasting.During their visit participants were interviewed for
collecting demographic and risk factor variables. Weight,
height and blood pressure were measured at the time of
the clinical examination performed. Body mass index
(BMI) was calculated from weight (kg) in light clothing
without shoes, and height (meters) without shoes. Obes-
ity was defined as a BMI ≥30 kg/m2. Blood pressure (BP)
was measured using a mercury sphygmomanometer in
the right upper arm in the sitting posture, after a five
minute rest and three measurements were averaged to
be recorded. Hypertension was defined as systolic BP
≥140 mmHg or diastolic BP ≥90 mmHg or use of anti-
hypertensive medication irrespective of the BP.
A blood sample was collected in the early morning
after an overnight fasting. Biochemical analysis were
done on HumaStar 80 clinical chemistry analyzer (Hu-
man Diagnostics, Germany) using kits supplied by HU-
MAN (Human Diagnostics, Germany). Fasting serum
glucose was measured by enzymatic GOD-PAP method.
SCr was measured using Jaffe kinetic method as mg/dl
with calibration traceable to IDMS reference material
NIST SRM 909B level 2.
Measurement of kidney function
Kidney function was assessed according to the simplified
version of the Modification of Diet in Renal Disease
(MDRD) study equation [14]: 186 × SCr(mg/dl)-1.154 ×
age(years)-0.203 × 0.742 (if female) × 1.210 (as our popu-
lation are Africans) and the Cockcroft-Gault (C-G) equa-
tion[15] normalized for the body surface area (BSA):
(140-age) ×Weight (Kg) × 0.86 (if female) × 1.73/72 ×
SCr (mg/dl) × BSA (m2).
All participants with eGFR < 60 ml/min/1.73 m2 at the
first visit were advised to have their serum checked for cre-
atinine two weeks after the first check-up. Staging of kidney
function was based on the National Kidney Foundation-
Disease Outcomes Quality Initiative (K/DOQI) classifica-
tion. Stage 1 CKD was defined as normal or increased
eGFR (eGFR ≥ 90 ml/min/1.73 m2). Mild, moderate, and
severe renal insufficiency (RI) corresponding to stage 2, 3
and 4 CKD were defined as eGFR 60–89.9, 30–59.9, and,
15–29.9 ml/min/1.73 m2, respectively. For the purposes of
this study, CKD was defined as eGFR <60 ml/min/1.73 m2
(stages 3–5 CKD)[1,18].
Statistical analysis
The data was entered in to “EpiInfo version 3.1” and was
analyzed using SPSS version 20.0 statistical software.
Data were expressed as means ± standard deviation (SD)
or percentage. Chi-square (x2) test was used to compare
proportions. Multivariate logistic regression was used to
calculate adjusted odds ratios (OR) and the correspond-
ing 95% confidence intervals (CI). P value < 0.05 was
used to indicate statistical significance.
Table 2 Prevalence of CKD according to K/DOQI
classification by different equations (n =214)






1 Normal or high GFR ≥90 118 (55.1) 84 (39.3)
2 Mild ↓GFR 60-89.9 57 (26.6) 79 (36.9)
3 Moderate ↓GFR 30-59.9 37 (17.3) 49 (22.9)
3A Mild to moderate
↓GFR
45-59.9 30 (14.0) 32 (15.0)
3B Moderate to
severe ↓GFR
30-44.9 7 (3.3) 17 (7.9)
4 Severe ↓GFR 15-29.9 2 (0.9) 2 (0.9)
Fiseha et al. BMC Nephrology 2014, 15:198 Page 3 of 5
http://www.biomedcentral.com/1471-2369/15/198Results
Demographic and clinical characteristics of participants
A total of 214 diabetic patients participated in the study,
123(57.5%) males, and 114 (53.3%) type 2 diabetics. Mean
age of participants was 45 ± 14.5 years, ranging from 19 to
90 years and 40 (18.7%) of them were above 60 years old.
Mean body mass index (BMI) was 25.26 ± 4.35Kg/m2, and
31 (14.5%) of them were obese (BMI ≥30 kg/m2). The mean
systolic and diastolic BP of participants was 121 ± 17 and
79 ± 10 mmHg, respectively and 113 (52.8%) were hyper-
tensive. Mean fasting serum glucose (FSG) was 172.85 ±
84.94 mg/dl. Mean serum creatinine (SCr) was 1.07 ±
0.33 mg/dl. The mean eGFR values according to the
MDRD and C-G equations were 96.70 ± 35.68 and 83.61 ±
29.73 ml/min/1.73 m2, respectively (Table 1).
Of the study participants, 18.2% by the MDRD equa-
tion and 23.8% by Cockcroft–Gault (C-G) equation had
CKD (defined as eGFR < 60 ml/min/1.73 m2). There was
no patient with eGFR <30 ml/min/1.73 m2. Only 48.7%
and 37.3% of participants with eGFR <60 ml/min/
1.73 m2 according to the MDRD and C-G equation, re-
spectively had SCr values >1.5 mg/dl (the relevant range
for detecting CKD [GFR <60 ml/min/1.73 m2]). Table 2
shows the prevalence of CKD according to the K/DOQI
classification using the MDRD and C-G equations.Table 1 Demographic and clinical characteristics of study
participants (n =214)
Characteristics
Age (year), means ± SD 45 ± 14.5
Age group, n (%) 18-49 Years 118 (55.2)
50-59 Years 56 (26.1)
60-69 Years 28 (13.1)
≥70 Years 12 (5.6)
Sex, n (%) Male 123 (57.5)
Female 91 (42.5)
Type of diabetes, n (%) Type 1 100 (46.7)
Type 2 114 (53.3)
Duration of diabetes, n (%) <5 Years 131 (61.2)
5-9.9 Years 48 (22.4)
≥10 Years 35 (16.4)
Family history kidney disease, n (%) 40 (18.7)
Systolic blood pressure (mmHg), means ± SD 121 ± 17
Diastolic blood pressure (mmHg), means ± SD 79 ± 10
Hypertension, n (%) 113 (52.8)
Body mass index (Kg/m2), means ± SD 25.26 ± 4.35
Fasting Serum Glucose (mg/dl), means ± SD 172.85 ± 84.94
Serum Creatinine (mg/dl), means ± SD 1.07 ± 0.33
eGFR MDRD (ml/min/1.73 m
2), means ± SD) 96.7 ± 35.68
eGFR C-G (ml/min/1.73 m
2), means ± SD 83.6 ± 29.73An increased risk of CKD was seen with: older age
(adjusted OR = 5.30, CI 1.81-15.56); female sex (adjusted
OR = 3.34, CI 1.38-8.10); longer duration of diabetes (ad-
justed OR = 4.08, CI 1.70-9.77); family history of kidney
disease (FH-KD) (adjusted OR = 3.16, CI 1.29-7.77);
obesity (adjusted OR = 2.75, CI 1.01-7.51) and poor glu-
cose control (high FSG) (adjusted OR = 4.65, CI 1.69-
12.76) when renal function was estimated by the MDRD
equation. Except for obesity and gender, the same pat-
tern was found when C-G formula was used. The type
of diabetes was associated with an increased risk of CKD
on multivariate logistic regression when using C-G equa-
tion to assess renal function.
From the total study subjects, normal SCr was ob-
served in 193 (90.2%) participants. Of these, 28.5% had
mild renal insufficiency (or stage 2 CKD) and 10.4% had
moderate renal insufficiency (or stage 3 CKD) despite
normal SCr when renal function was estimated by the
MDRD equation. When renal function was estimated
using C-G equation, 39.9% and 16.6% of those with nor-
mal SCr were found to have mild and moderate renal in-
sufficiency or stage 2 and 3 CKD, respectively (Table 3).
The prevalence of CKD i.e. eGFR <60 ml/min/1.73 m2
among participants with normal SCr increased signifi-
cantly with each age category, from 1.8% for age <49 years
to 22.2 and 66.7% for age ≥70 years (all P < 0.001) accord-
ing to the MDRD and C-G, respectively. CKD was also
higher in female participants with normal SCr comparedTable 3 Kidney function among participants with
normal serum creatinine according to the MDRD and







≥90 Stage 1 CKD Normal renal
function
118 (61.1) 84 (43.5)
60 - 89.9 Stage 2 CKD Mild Renal
Insufficiency
55 (28.5) 77 (39.9)
30 - 59.9 Stage 3 CKD Moderate Renal
Insufficiency
20 (10.4) 32 (16.6)
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27.1% and 8.3% (P = 0.001) by C-G.
Compared with patients with eGFR ≥60 ml/min/1.73 m2,
patients with eGFR <60 ml/min/1.73 m2 and normal SCr
were older, had high BMI, fasting glucose and serum cre-
atinine when the MDRD equation was used to assess renal
function. Similarly, participants with eGFR <60 ml/min/
1.73 m2 despite normal SCr levels were older, had signifi-
cantly increased systolic BP, fasting glucose and SCr when
renal function was assessed by C-G.
Discussion
As diabetics are more likely to have CKD than those
without diabetics, and thus suffer extra morbidity and
mortality; regular assessment of renal function allows
early identification of CKD and creates the opportunity
for intervention to improve adverse outcomes [2,10,17].
Although several studies show a high prevalence of CKD
in patients with diabetics, ranging between 15.1–33.1%
[16,19], this study is the first to describe the prevalence
of CKD among diabetic adults in Ethiopia using equa-
tions to estimate GFR.
In this study, CKD (eGFR <60 ml/min/1.73 m2) was
found in 18.2–23.8% participants depending on the for-
mula used to estimate GFR, with stage 3 being dominant
(from 17.3 to 22.9%). Our prevalence estimate of CKD
using the MDRD equation was higher than the US
NHANES III study [16], which reported 15.1%, and
closer to 24.7% reported in Tanzania, sub-Sahara African
study using C-G equation [20]. However, our prevalence
estimate of CKD using a similar definition of eGFR was
lower than that of 27.5% and 31% reported in two UK
studies [17,21], and 33.1% reported in Japanese study
[19]. These differences in prevalence might be because
of the differences in creatinine assays and calibration or
differences in case-mix.
Despite this high prevalence, many patients were undiag-
nosed because renal function is usually assessed according
to the levels of SCr and not to estimate GFR (eGFR). Only
9.8% of the total participants and 48.7% (for the MDRD)
and 37.3% (for C-G) of those with eGFR < 60 ml/min/
1.73 m2 had SCr values >1.5 mg/dl (the relevant range
for detecting CKD [GFR <60 ml/min/1.73 m2]) [22].
In two different studies, 33 to 45.3% of diabetics with
eGFR <60 ml/min/1.73 m2 have shown to have raised SCr
[17,21]. Accordingly, SCr failed to detect a significant num-
ber of patients with eGFR <60 ml/min/1.73 m2.
Analyses presented here also show that, a considerable
number of participants ranging from 38.9-56.5% have
shown to have mild to moderate RI (stages 2–3 CKD) des-
pite normal SCr levels. A study from Poland also reported
a high prevalence of CKD up to 77%, on the basis of eGFR
(from 62.8% to 76.9%), among diabetic patients with nor-
mal SCr [10]. In our study, CKD i.e. eGFR < 60 ml/min/1.73 m2, was found in 10.4% (for the MDRD) and 16.9%
(for C-G) of participants with normal SCr. In the above
study, 13.0% and 22.4% of diabetics with normal SCr had
eGFR < 60 ml/min/1.73 m2 according to the MDRD and
C-G equations, respectively which is comparable to our
results. Thus, depending on normal SCr as evidence of
normal renal function will result in missing a substantial
proportion of patients with RI.
Furthermore, the rate of undiagnosed CKD defined as
eGFR < 60 ml/min/1.73 m2 without evidence of abnor-
mal SCr was higher in females and in the elderly. This
study shows that the proportion of persons with undiag-
nosed CKD increased with age; account for the fact that
younger people have a higher GFR than older people at the
same level of SCr and may translate to late diagnosis of
kidney disease. Undiagnosed CKD is also associated with
high BMI, fasting glucose and serum creatinine by the
MDRD equation, and with high systolic blood pressure,
fasting glucose and serum creatinine by C-G equation.
Therefore, as stressed by current guidelines SCr alone
should not be used to assess kidney function because it
fails to identify many patients whose kidney function is
reduced while their SCr is still in the normal range
[1,13]. As SCr is affected by several factors including
age, sex, race, and body size, estimation of GFR using
prediction equations is recommended to avoid the mis-
classification of individuals on the basis of SCr alone
[14,15]. Furthermore, it has been shown that the degree
of kidney dysfunction in diabetes, as assessed by the
eGFR, is an independent predictor of adverse outcomes
in these patents [2,23].
Although several equations that estimate GFR from
SCr have been developed, the MDRD and C-G are the
commonly used in clinical practice. The MDRD equa-
tion that was developed using data from patients with
established CKD as measured by 125I-iothalamate clear-
ance adjusted for BSA is quick and easy to calculate on
all patients using data routinely provided when request-
ing a SCr measurement. The equation differs from the
C-G in several ways including that it does not require
knowledge of the patient’s weight and has been generally
shown to be more precise and accurate in predicting the
GFR in patients with GFR < 60 ml/min/1.73 m2 [24,25].
On the contrary, the C-G equation requires normalisation
for BSA, estimates creatinine clearance rather than GFR,
and because of the inclusion of weight in the numerator,
as a measure of muscle mass, the equation overestimates
the GFR in overweight and obese diabetics [26].
Although this study is the first of its type, it has some
limitations. First, proteinuria has not been included since
a standardized method for measuring albuminuria was
not available, thus possibly leading to underestimation of
the actual prevalence of CKD. Second, calculated GFR
rather than measured GFR was used to diagnose renal
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MDRD study equation has not been validated among Ethi-
opian diabetic adults. Lastly, the measurement of serum
creatinine was not standardized; this might influence the
performance of eGFR equations. Our study also has major
strength, the diagnosis of CKD based on eGFR on multiple
measures of SCr to establish chronicity.
Conclusion
In conclusion, this study demonstrated that CKD is
present in no less than 18% of diabetic patients attend-
ing Butajira hospital of southern Ethiopia, but it is usu-
ally undiagnosed. Furthermore, the prevalence of renal
insufficiency corresponding to stages 2–3 CKD is high
in diabetics despite normal creatinine levels. Therefore,
selecting appropriate methods of assessing renal func-
tion can identify an important proportion of diabetic pa-
tients that are at increased risk for cardiovascular and
renal outcomes.
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